Henrik von Euler

2.6k total citations
30 papers, 1.7k citations indexed

About

Henrik von Euler is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Henrik von Euler has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Henrik von Euler's work include Veterinary Oncology Research (16 papers), Infectious Diseases and Mycology (7 papers) and Virus-based gene therapy research (6 papers). Henrik von Euler is often cited by papers focused on Veterinary Oncology Research (16 papers), Infectious Diseases and Mycology (7 papers) and Virus-based gene therapy research (6 papers). Henrik von Euler collaborates with scholars based in Sweden, United States and Germany. Henrik von Euler's co-authors include Patricio Rivera, Åke Hedhammar, Kerstin Lindblad‐Toh, Agneta Egenvall, Anne‐Sofie Lagerstedt, Tara Biagi, Jerker M. Olsson, Göran Andersson, Elinor K. Karlsson and Claire M. Wade and has published in prestigious journals such as Nature Genetics, PLoS ONE and Cancer Research.

In The Last Decade

Henrik von Euler

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik von Euler Sweden 20 731 627 513 332 189 30 1.7k
Catrin S. Rutland United Kingdom 22 278 0.4× 245 0.4× 713 1.4× 158 0.5× 58 0.3× 112 1.9k
E. van Garderen Netherlands 23 330 0.5× 577 0.9× 732 1.4× 349 1.1× 85 0.4× 46 2.3k
Valentina Zappulli Italy 22 334 0.5× 1.3k 2.1× 911 1.8× 619 1.9× 81 0.4× 69 2.5k
Édouard Cadieu France 18 578 0.8× 313 0.5× 549 1.1× 196 0.6× 36 0.2× 29 1.3k
Anne E. Peaston Australia 20 358 0.5× 311 0.5× 993 1.9× 136 0.4× 26 0.1× 46 1.6k
Christine L. Halbert United States 22 1.9k 2.6× 157 0.3× 1.7k 3.3× 156 0.5× 35 0.2× 39 2.6k
Dolors Fondevila Spain 24 143 0.2× 358 0.6× 343 0.7× 172 0.5× 28 0.1× 93 1.9k
Silke Glage Germany 26 289 0.4× 155 0.2× 1.5k 2.9× 124 0.4× 19 0.1× 80 2.5k
Donald Bellgrau United States 25 645 0.9× 182 0.3× 1.0k 2.0× 53 0.2× 159 0.8× 78 2.7k
Maja M. Suter Switzerland 23 209 0.3× 182 0.3× 496 1.0× 101 0.3× 21 0.1× 71 1.8k

Countries citing papers authored by Henrik von Euler

Since Specialization
Citations

This map shows the geographic impact of Henrik von Euler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik von Euler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik von Euler more than expected).

Fields of papers citing papers by Henrik von Euler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik von Euler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik von Euler. The network helps show where Henrik von Euler may publish in the future.

Co-authorship network of co-authors of Henrik von Euler

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik von Euler. A scholar is included among the top collaborators of Henrik von Euler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik von Euler. Henrik von Euler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nostell, Katarina, et al.. (2015). Serum thymidine kinase activity in clinically healthy and diseased horses: A potential marker for lymphoma. The Veterinary Journal. 205(2). 313–316. 21 indexed citations
2.
Ahlgren, Kerstin M., Tove Fall, Nils Landegren, et al.. (2014). Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus. PLoS ONE. 9(8). e105473–e105473. 32 indexed citations
3.
4.
Svensson, Emma, Maria Dimopoulou, Olle Korsgren, et al.. (2013). Treatment Efficacy and Immune Stimulation by AdCD40L Gene Therapy of Spontaneous Canine Malignant Melanoma. Journal of Immunotherapy. 36(6). 350–358. 51 indexed citations
5.
Borge, Kaja Sverdrup, Malin Melin, Patricio Rivera, et al.. (2013). The ESR1 gene is associated with risk for canine mammary tumours. BMC Veterinary Research. 9(1). 69–69. 15 indexed citations
6.
Euler, Henrik von, et al.. (2012). A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma. The Veterinary Journal. 194(1). 40–47. 24 indexed citations
7.
Stålhandske, Per, Liya Wang, Henrik von Euler, et al.. (2012). Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities. Analytical Biochemistry. 432(2). 155–164. 4 indexed citations
8.
Euler, Henrik von & S. Eriksson. (2010). Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases. Veterinary and Comparative Oncology. 9(1). 1–15. 29 indexed citations
9.
Eriksson, Marie, Henrik von Euler, Elisabet Ekman, et al.. (2009). Surfactant Protein C in Canine Pulmonary Fibrosis. Journal of Veterinary Internal Medicine. 23(6). 1170–1174. 6 indexed citations
10.
Euler, Henrik von, Björn Carlsson, Patricio Rivera, et al.. (2008). Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant Melanoma. Journal of Immunotherapy. 31(4). 377–384. 41 indexed citations
11.
Karlsson, Elinor K., Claire M. Wade, Michael C. Zody, et al.. (2007). Efficient mapping of mendelian traits in dogs through genome-wide association. Nature Genetics. 39(11). 1321–1328. 412 indexed citations
12.
Egenvall, Agneta, Brenda N. Bonnett, Patrik Öhagen, et al.. (2005). Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Preventive Veterinary Medicine. 69(1-2). 109–127. 179 indexed citations
13.
Euler, Henrik von, et al.. (2005). Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. International Journal of Molecular Medicine. 16(6). 979–85. 11 indexed citations
14.
Euler, Henrik von, R. Einarsson, Ulf Olsson, Anne‐Sofie Lagerstedt, & Staffan Eriksson. (2004). Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease. Journal of Veterinary Internal Medicine. 18(5). 696–702. 22 indexed citations
15.
Euler, Henrik von, R. Einarsson, Ulf Olsson, Anne‐Sofie Lagerstedt, & Staffan Eriksson. (2004). Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease. Journal of Veterinary Internal Medicine. 18(5). 696–696. 46 indexed citations
16.
Euler, Henrik von, Jerker M. Olsson, Kjell Hultenby, Anders Thörne, & Anne‐Sofie Lagerstedt. (2003). Animal models for treatment of unresectable liver tumours: a histopathologic and ultra-structural study of cellular toxic changes after electrochemical treatment in rat and dog liver. Bioelectrochemistry. 59(1-2). 89–98. 29 indexed citations
17.
Euler, Henrik von, et al.. (2003). Cell proliferation and apoptosis in rat mammary cancer after electrochemical treatment (EChT). Bioelectrochemistry. 62(1). 57–65. 19 indexed citations
18.
19.
Euler, Henrik von, Eva Nilsson, Jerker M. Olsson, & Anne‐Sofie Lagerstedt. (2001). Electrochemical treatment (EChT) effects in rat mammary and liver tissue. In vivo optimizing of a dose-planning model for EChT of tumours. Bioelectrochemistry. 54(2). 117–124. 31 indexed citations
20.
Nilsson, Eva, Henrik von Euler, Anders Thörne, et al.. (2000). Electrochemical treatment of tumours. Bioelectrochemistry. 51(1). 1–11. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catrin S. Rutland Breakdown of academic impact, for papers by E. van Garderen Breakdown of academic impact, for papers by Valentina Zappulli Breakdown of academic impact, for papers by Édouard Cadieu Breakdown of academic impact, for papers by Anne E. Peaston Breakdown of academic impact, for papers by Christine L. Halbert Breakdown of academic impact, for papers by Dolors Fondevila Breakdown of academic impact, for papers by Silke Glage Breakdown of academic impact, for papers by Donald Bellgrau Breakdown of academic impact, for papers by Maja M. Suter
Rankless by CCL
2026